SCHEMBL2415282

SCHEMBL2415282

OCCN1CCCCCN1

nearest known ligand 0.33

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
CA2 P00918 1/20 0.31
CHKA P35790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18432567 0.98
SCHEMBL2278325 0.91
SCHEMBL16104765 0.83
SCHEMBL15824158 0.81
SCHEMBL29569422 0.77 ALOX15 (0.35)
SCHEMBL3635059 0.77
SCHEMBL29569270 0.77 ALOX15 (0.35)
SCHEMBL27632519 0.77 MAPT (0.50) CA2CHKA
SCHEMBL9449545 0.76 CXCR4 (0.35)
SCHEMBL18432572 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1312606-B1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres OREAL (FR) 2011-09-21 EP claimed
EP-1336606-B1 6-Alkoxy-2,3-diaminopyridine couplers for dyeing keratin fibers OREAL (FR) 2006-12-27 EP claimed
US-6916345-B2 6-alkoxy-2,3-diaminopyridine couplers for dyeing keratin fibres L'OREAL S.A. (FR) 2005-07-12 US claimed
US-6837908-B2 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2005-01-04 US claimed
US-20030226216-A1 Novel 6-alkoxy-2,3-diaminopyridine couplers for dyeing keratin fibres L'OREAL S.A. (FR) 2003-12-11 US claimed
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2003-09-04 US claimed
EP-1336606-A1 6-Alkoxy-2,3-diaminopyridine couplers for dying keratin fibers L'OREAL (FR) 2003-08-20 EP claimed
EP-1312606-A1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres L'OREAL (FR) 2003-05-21 EP claimed
EP-1312606-B1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres OREAL (FR) 2011-09-21 EP disclosed
US-7179307-B2 Use of an extract of myrsine africana in oxidation dyeing for dyeing keratin fibres L'OREAL, S.A. (FR) 2007-02-20 US disclosed
US-20060010618-A1 Use of an extract of Myrsine africana in oxidation dyeing for dyeing keratin fibres L'OREAL S.A. 2006-01-19 US disclosed
US-6974485-B2 Use of an extract of Myrsine africana in oxidation dyeing for dyeing keratin fibres L'OREAL S.A. (FR) 2005-12-13 US disclosed
US-6916345-B2 6-alkoxy-2,3-diaminopyridine couplers for dyeing keratin fibres L'OREAL S.A. (FR) 2005-07-12 US disclosed
EP-1312347-B1 Use of an extract of myrsine africana for the oxidative dyeing of keratinic fibres OREAL (FR) 2005-02-02 EP disclosed
US-6837908-B2 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2005-01-04 US disclosed
US-20030226216-A1 Novel 6-alkoxy-2,3-diaminopyridine couplers for dyeing keratin fibres L'OREAL S.A. (FR) 2003-12-11 US disclosed
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2003-09-04 US disclosed
US-20030115687-A1 Use of an extract of Myrsine africana in oxidation dyeing for dyeing keratin fibres L'OREAL S.A. (FR) 2003-06-26 US disclosed
EP-1312347-A1 Use of an extract of myrsine africana for the oxidative dyeing of keratinic fibres L'OREAL (FR) 2003-05-21 EP disclosed
EP-1312606-A1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres L'OREAL (FR) 2003-05-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030226216-A1 Novel 6-alkoxy-2,3-diaminopyridine couplers for dyeing keratin fibres KRT18, DSP, DPYD MEN1 4578/4885CYP3A4 2741/4885CYP2C9 1878/4885
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres KRT18, DPYD, DSP MEN1 4750/4885CYP3A4 2704/4885CYP2C9 1692/4885
US-20060010618-A1 Use of an extract of Myrsine africana in oxidation dyeing for dyeing keratin fibres KRT18, TUBB8, TUBB MEN1 4344/4885CYP3A4 1630/4885CYP2C9 1739/4885
US-20030115687-A1 Use of an extract of Myrsine africana in oxidation dyeing for dyeing keratin fibres KRT18, TUBB8, TUBB MEN1 4344/4885CYP3A4 1630/4885CYP2C9 1739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.